Sarah A. Teichmann - 30 Aug 2024 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Sarah A. Teichmann
Issuer symbol
TXG
Transactions as of
30 Aug 2024
Net transactions value
$0
Form type
4
Filing time
04 Sep 2024, 17:34:30 UTC
Previous filing
19 Jul 2024
Next filing
05 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Award $0 +19,002 $0.000000 19,002 30 Aug 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/3rd of the RSUs shall vest on November 21, 2025 and 1/12th of the RSUs shall vest on each quarterly anniversary thereafter for the following two years, subject to the Reporting Person continuing as a service provider through each such date.